Legal & General Group’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $26.5K | Hold |
|
|||||
|
2025
Q2 | $25.1K | Hold |
|
|||||
|
2025
Q1 | $24.4K | Hold |
|
|||||
|
2024
Q4 | $25.5K | Hold |
|
|||||
|
2024
Q3 | $24.9K | Buy |
|
|||||
|
2024
Q2 | $26K | Sell |
|
|||||
|
2024
Q1 | $25.8K | Sell |
|
|||||
|
2023
Q4 | $37.5K | Sell |
|
|||||
|
2023
Q3 | $190K | Sell |
|
|||||
|
2023
Q2 | $1.02M | Buy |
|
|||||
|
2023
Q1 | $941K | Sell |
|
|||||
|
2022
Q4 | $1.04M | Buy |
|
|||||
|
2022
Q3 | $1.35M | Buy |
|
|||||
|
2022
Q2 | $1.47M | Buy |
|
|||||
|
2022
Q1 | $1.51M | Sell |
|
|||||
|
2021
Q4 | $2.12M | Buy |
|
|||||
|
2021
Q3 | $2.23M | Buy |
|
|||||
|
2021
Q2 | $2.55M | Sell |
|
|||||
|
2021
Q1 | $2.32M | Buy |
|
|||||
|
2020
Q4 | $1.99M | Sell |
|
|||||
|
2020
Q3 | $1.47M | Buy |
|
|||||
|
2020
Q2 | $1.72M | Buy |
|
|||||
|
2020
Q1 | $1.48M | Buy |
|
|||||
|
2019
Q4 | $2.27M | Buy |
|
|||||
|
2019
Q3 | $1.7M | Buy |
|
|||||
|
2019
Q2 | $1.75M | Buy |
|
|||||
|
2019
Q1 | $2.29M | Buy |
|
|||||
|
2018
Q4 | $2.9M | Buy |
|
|||||
|
2018
Q3 | $2.56M | Buy |
|
|||||
|
2018
Q2 | $154K | Buy |
|
|||||
|
2018
Q1 | $136K | Sell |
|
|||||
|
2017
Q4 | $176K | Sell |
|
|||||
|
2017
Q3 | $227K | Buy |
|
|||||
|
2017
Q2 | $181K | Buy |
|
|||||
|
2017
Q1 | $113K | Sell |
|
|||||
|
2016
Q4 | $131K | Buy |
|
|||||
|
2016
Q3 | $95K | Sell |
|
|||||
|
2016
Q2 | $71K | Hold |
|
|||||
|
2016
Q1 | $52K | Hold |
|
|||||
|
2015
Q4 | $61K | Hold |
|
|||||
|
2015
Q3 | $73K | Hold |
|
|||||
|
2015
Q2 | $82K | Hold |
|
|||||
|
2015
Q1 | $60K | Hold |
|
|||||
|
2014
Q4 | $96K | Hold |
|
|||||
|
2014
Q3 | $67K | Buy |
|